SINTX Technologies Inc (NASDAQ:SINT) shares traded 1.22% higher at $0.02 on Wall Street last session.
SINT stock price is now -81.08% away from the 50-day moving average and -96.08% away from the 200-day moving average. The market capitalization of the company currently stands at $1.27M.
A total of 0.05% of the company’s stock is owned by insiders.
During the past 12 months, SINTX Technologies Inc has had a low of $0.02 and a high of $2.19. As of last week, the company has a debt-to-equity ratio of 0.48, a current ratio of 1.90, and a quick ratio of 1.60. The fifty day moving average price for SINT is $0.1259 and a two-hundred day moving average price translates $0.6257 for the stock.
The latest earnings results from SINTX Technologies Inc (NASDAQ: SINT) was released for Sep, 2023. According to the Medical Devices Company, earnings per share came in at -$0.39, beating analysts’ expectations of -$0.75 by 0.36. This compares to -$14.16 EPS in the same period last year. The net profit margin was -315.38% and return on equity was -114.11% for SINT. The company reported revenue of $0.9 million for the quarter, compared to $0.77 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 17.75 percent. For the current quarter, analysts expect SINT to generate $690k in revenue.
SINTX Technologies Inc(SINT) Company Profile
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
